Related Experiment Video
Updated: Sep 13, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Paradoxical interaction between dalbavancin and β-lactams against endocarditis-associated Enterococcus faecalis
David Luque Paz1,2, Adrien Turban2,3, François Guérin2,3,4
1Infectious Diseases Department, Pontchaillou University Hospital, Rennes, France.
Dalbavancin shows poor activity against Enterococcus faecalis and can reduce the effectiveness of beta-lactams like amoxicillin. Caution is advised when using dalbavancin for E. faecalis infections, particularly endocarditis.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Limited in vitro studies exist on dalbavancin synergy with enterococci.
- Enterococcus faecalis is a significant pathogen, often requiring combination therapy.
Purpose of the Study:
- To evaluate the in vitro activity of dalbavancin against E. faecalis.
- To investigate the interaction between dalbavancin and beta-lactam antibiotics.
Main Methods:
- Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) determination.
- Checkerboard assays for initial interaction screening.
- Time-kill (TK) assays to confirm synergy or antagonism with beta-lactams.
Main Results:
- E. faecalis strains demonstrated tolerance to dalbavancin (MBC/MIC >32).
- Synergy was observed between dalbavancin and beta-lactams at sub-inhibitory concentrations in TK assays.
- Antagonism was noted when dalbavancin was combined with amoxicillin, ceftobiprole, or ertapenem at higher concentrations, significantly reducing bacterial killing compared to beta-lactams alone.
Conclusions:
- Dalbavancin exhibits limited efficacy against E. faecalis.
- Dalbavancin can impair the activity of beta-lactams, notably amoxicillin.
- Clinical use of dalbavancin for E. faecalis infective endocarditis warrants caution due to potential antagonistic effects.
Related Concept Videos
Endocarditis III: Medical Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Antimicrobial Effectiveness

